Sign in

CIK 0001824893

  • Non-accelerated filer
  • Smaller reporting company

Surrozen, Inc./DE

Sign in to watch
Ticker
SRZN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
301374889
Phone
+1 650-475-2820
Business address
171 OYSTER POINT BLVD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Former names
Consonance-HFW Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-02-01 Williams Charles O Chief Financial Officer Grant or award · Option (right to buy) +125,000 125,000
2023-02-01 Yeh Wen-Chen Chief Scientific Officer Grant or award · Option (right to buy) +125,000 125,000
2022-12-15 Yeh Wen-Chen Chief Scientific Officer Grant or award +9,578 $0.41 $4K 229,138
2022-12-15 Parker Craig C Chief Executive Officer Grant or award +9,578 $0.41 $4K 9,578
2022-12-15 Vanhove Geertrui Chief Medical Officer Grant or award +9,578 $0.41 $4K 32,412
2022-12-15 Williams Charles O Chief Financial Officer Grant or award +9,578 $0.41 $4K 9,578
2022-12-14 BLUTT MITCHELL J MD 10% owner Sale −1,748,750 0
2022-12-14 BLUTT MITCHELL J MD 10% owner Sale −1,297,922 0
2022-12-14 BLUTT MITCHELL J MD 10% owner Sale −450,827 0
2022-12-14 BLUTT MITCHELL J MD 10% owner Sale −1,885,000 0
2022-12-14 BLUTT MITCHELL J MD 10% owner Sale · Warrants (right to buy) −582,916 0
2022-12-14 BLUTT MITCHELL J MD 10% owner Sale · Warrants (right to buy) −432,639 0
2022-12-14 BLUTT MITCHELL J MD 10% owner Sale · Warrants (right to buy) −150,275 0
2022-12-14 BLUTT MITCHELL J MD 10% owner Sale · Warrants (right to buy) −144,666 0
2022-10-10 Vanhove Geertrui Chief Medical Officer Returned to the company · Option (right to buy) −24,587 0
2022-10-10 Vanhove Geertrui Chief Medical Officer Returned to the company · Option (right to buy) −10,427 0
2022-10-10 Vanhove Geertrui Chief Medical Officer Returned to the company · Option (right to buy) −26,220 0
2022-10-10 Vanhove Geertrui Chief Medical Officer Returned to the company · Option (right to buy) −1,760 0
2022-10-10 Vanhove Geertrui Chief Medical Officer Grant or award · Option (right to buy) +26,220 26,220
2022-10-10 Vanhove Geertrui Chief Medical Officer Grant or award · Option (right to buy) +10,427 10,427

Page 13 of 20 · 398 trades